• Refine Query
  • Source
  • Publication year
  • to
  • Language
  • 863
  • 792
  • 126
  • 98
  • 54
  • 47
  • 45
  • 39
  • 26
  • 21
  • 21
  • 21
  • 21
  • 21
  • 21
  • Tagged with
  • 2448
  • 806
  • 687
  • 642
  • 361
  • 315
  • 300
  • 299
  • 282
  • 205
  • 199
  • 187
  • 180
  • 165
  • 145
  • About
  • The Global ETD Search service is a free service for researchers to find electronic theses and dissertations. This service is provided by the Networked Digital Library of Theses and Dissertations.
    Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.
711

Análise comparativa do potencial de migração de células-tronco imaturas de polpa dentária humana em ratos induzidos a necrose tubular aguda utilizando as vias: intraperitoneal e endovenosa / Comparative analysis of the potential for migration of immature stem cells from human dental pulp in rats induced acute tubular necrosis using routes: intraperitoneal and intravenous

Barros, Michele Andrade de 31 May 2011 (has links)
Pesquisas com células tronco têm demonstrado que essa alternativa terapêutica tem grande potencial em diversas patologias. Contudo, muito ainda precisa ser elucidado quanto aos mecanismos de ação, dose e melhores vias de aplicação, para que essa alternativa terapêutica seja efetivamente incorporada às outras. Neste contexto, a via de aplicação se torna crucial na efetividade do tratamento. O objetivo do presente estudo foi avaliar no modelo de necrose tubular aguda (NTA) induzido pelo glicerol o potencial de migração das células tronco mesenquimais derivadas de polpa dentária humana, utilizando as vias intraperitoneal e a via intravenosa. Os nossos resultados demonstraram que neste modelo, não há diferença na migração das células para o órgão alvo, o rim. Contudo, a via intravenosa proporcionou uma melhora da função renal mais significativa do que quando comparada a via intraperitoneal. / Stem cell research have demonstrated that this alternative therapy has great potential in various diseases. However, much remains to be elucidated about the mechanisms of action, dosage and best means of implementation, so that alternative therapy may be incorporated other. In this context, the route of application becomes crucial in the effectiveness of treatment. The aim of this study was to evaluate the model of acute tubular necrosis (NTA) induced by glycerol the potential for migration of mesenchymal stem cells derived from human dental pulp, using the intraperitoneal and intravenous route. Our results demonstrate that this model, there is no difference in cell migration to the target organ, the kidney. However, the intravenous route provided an improvement in renal function more significantly than when compared to the intraperitoneal route.
712

Avaliação do efeito do pré e pós-condicionamento em modelo de isquemia renal transitória estudo comparativo experimental em ratos /

Arantes, Vinicius Monteiro January 2016 (has links)
Orientador: Noma Sueli Pinheiro Modolo / Resumo: Introdução: a lesão por isquemia-reperfusão (LIR) é uma importante causa de lesãorenal aguda experimentada na prática clínica. A restauração da perfusão aos tecidosapós um período de isquemia inicia uma cascata de inflamação associada ao acúmulode íons, formação de espécies reativas de oxigênio (ERO), disfunção endotelial eativação imune. O condicionamento isquêmico é a aplicação de breves ciclos deinterrupção seguidas de restauração do fluxo sanguíneo, tendo o objetivo de adaptaros tecidos à isquemia. Pode ser aplicado antes do estímulo principal, como précondicionamento(PCI), ou depois, sendo denominado pós-condicionamento (PCoI).Metodologia: estudo experimental realizado com 40 ratos wistar, divididos em cincogrupos para análise comparativa: Sham (S): laparotomia; Controle (C): laparotomia e30 min de isquemia; Pré-condicionamento (PRE): laparotomia, PCI e 30 min deisquemia; Pré e Pós-condicionamento (PRE/POS): laparotomia, PCI, 30 min deisquemia e PCoI; Pós-condicionamento (POS): laparotomia, 30 min de isquemia ePCoI. A comparação entre os grupos foi realizada pela análise bioquímica sérica decreatinina, ureia, lipocalina associada à gelatinase de neutrófilos (NGAL) e histolologia.Resultados: apenas o grupo Sham apresentou valores estatisticamente menores dosmarcadores de lesão renal e menor incidência de lesão tubular renal à histologia(S<C=PRÉ=PRÉ/PÓS=PÓS).Discussão e conclusão: no presente estudo, o PCI e o PoCI, isoladamente ou emc... (Resumo completo, clicar acesso eletrônico abaixo) / Abstract: Background: Ischemia-reperfusion injury (IRI) is an unavoidable aspect of transplantation, as well as an important cause of acute kidney injury in clinical practice. Restoration of the blood supply after an ischemic period activates an inflammatory cascade associated with multiple processes, including ion accumulation, free reactive oxygen species (ROS) formation, endothelial dysfunction, and immune activation. Ischemic “conditioning” refers to the application of a brief series of ischemic periods followed by reperfusion in the setting of major ischemia. In ischemic preconditioning (IPC), the conditioning stimulus is applied before the major ischemic event, whereas in ischemic postconditioning (IPoC), it is applied after the event. Methods: Forty Wistar rats were randomized into five groups: Sham (S): laparotomy; Control (C): laparotomy and 30 min ischemia; Preconditioning (PRE): laparotomy, IPC, and 30 min ischemia; Preconditioning and Postconditioning (PRE/POST): laparotomy, IPC, 30 min ischemia, and IPoC; Postconditioning (POST): laparotomy, 30 min ischemia, and IPoC. Serum analyses of creatinine and neutrophil gelatinaseassociated lipocalin (NGAL) were performed, and renal histology was also examined. Results: Severe tubular injury and increases in creatinine were observed in all groups except the S group, and no significant differences were detected between the other groups (S<C=PRE=PRE/POST=POST). Conclusions: IPC and IPoC, together or separately, were unable to exert a... (Complete abstract click electronic access below) / Doutor
713

Efeitos do Aspartame no Rim Fetal: Estudo Experimental em Ratas.

Martins, Marielza Regina Ismael 08 March 2007 (has links)
Made available in DSpace on 2016-01-26T12:51:11Z (GMT). No. of bitstreams: 1 marielzaismaelmartins_tese.pdf: 995891 bytes, checksum: 0b6650b7225cb745138cabdd1074db51 (MD5) Previous issue date: 2007-03-08 / Introduction: Aspartame is a widely used artificial sweetener added to many products of foods and beverages, being 200 times as sweet as sugar. Objective: evaluating the effect of aspartame in kidneys of rats fetuses considering morpholmetric changes of glomeruli, proximal and distal convoluted tubules and, colleting duct. Material and Method: Fifteen pregnant Wistar rats weighting around 240gr divided into three groups: control group (n = 5), treated group with aspartame at room temperature (n = 5) and treated group with aspartame heated to 40&#61616;C (n = 5). The treatment with aspartame occurred on the 9&#61616;, 10&#61616; and 11&#61616; day of pregnancy. A dose of 14mg/Kg of body weight during organogenesis. In the 20th day of pregnancy, animals were sacrificed and the fetuses were fixed in Alfac solution and the kidneys included in paraffin, sectioned an stained with hematoxiline-eosine. A morphometric study used karyometry and stereology. Results: There were significant decreases in fetal weight in treated group with aspartame at room temperature (p=0,004) when compared with control group. The Karyometric have allowed evaluation modification of cell nuclei with significant variation in the glomeruli, proximal and distal convoluted tubules and, lower degree in the colleting ducts of treated fetuses. Stereological parameters showed an increase in the cellular volume and reduction in the numerical cellular density when the control and treated groups with aspartame heated to 40&#61616;C are statistically compared. Conclusions: These results showed that use of aspartame produced alterations in every kidney structures suggesting nefrotoxicity. / Introdução: O aspartame é um edulcorante artificial amplamente usado em muitos produtos como alimentos e bebidas sendo 200 vezes mais doce que o açúcar. Objetivo: avaliar o efeito do aspartame em rins de fetos de ratas considerando as alterações morfométricas no glomérulo, túbulos contorcidos proximais e distais e ducto coletor. Material e Método: 15 ratas grávidas, pesando em média 240gr foram divididas em 3 grupos: grupo controle(n=5), grupo tratado com aspartame á temperatura ambiente(n=5) e, grupo tratado com aspartame aquecido á 40&#61616;C (n=5). Os animais foram expostos ao aspartame nos 9°, 10° e 11° dias de prenhez. A dosagem é de 14 mg/kg de peso durante a organogênese. No 20&#61616; dia da prenhez, os animais foram mortos e os fetos fixados em solução Alfac, e os rins incluídos em parafina, cortados e estabilizados com hematoxilina-eosina. O método utilizado foi a morfometria pelas técnicas cariométrica e estereológica. Resultados: Houve diminuição significativa no peso dos fetos do grupo tratado com aspartame á temperatura ambiente (p=0,004) comparado com o grupo controle. A cariometria permitiu avaliar as modificações dos núcleos celulares, com variações significantes nos glomérulos, túbulos contorcidos proximais e distais e, em menor grau nos ductos coletores dos fetos tratados. Os parâmetros estereológicos mostraram um aumento no volume celular e redução na densidade numérica celular quando os grupos controle e tratado com aspartame aquecido a temperatura de 40&#61616;C foram comparados estatisticamente. Conclusão: Estes resultados mostraram que o uso do aspartame produz alterações em todas as estruturas renais sugerindo nefrotoxicidade.
714

To study the pharmacokinetics of cyclosporine A in Hong Kong Chinese stable renal transplant patients by a rapid and simple liquid chromatography tandem mass spectrometry.

January 2002 (has links)
Law Wai Keung. / Thesis (M.Sc.)--Chinese University of Hong Kong, 2002. / Includes bibliographical references (leaves 98-108). / Abstracts in English and Chinese. / Abstract --- p.v / 摘要 --- p.viii / Acknowledgement --- p.x / List of Abbreviations --- p.i / Index of tables --- p.xiv / Index of figures --- p.xv / Chapter 1. --- Introduction --- p.1 / Chapter 2. --- Literature review --- p.3 / Chapter 2.1 --- Immunosuppression in Organ Transplantation --- p.3 / Chapter 2.2 --- Mechanism of Graft Rejection --- p.4 / Chapter 2.3 --- Conventional immunosuppressive drugs --- p.4 / Chapter 2.3.1 --- Corticosteriod --- p.6 / Chapter 2.3.2 --- Azathioprine --- p.6 / Chapter 2.3.3 --- Polyclonal antilymphocyte globulin and OKT3 --- p.7 / Chapter 2.4 --- Cyclosporine A (CsA) --- p.8 / Chapter 2.4.1 --- Mechanisms of CsA --- p.8 / Chapter 2.4.2 --- Pharmacokinetics of CsA --- p.10 / Chapter 2.4.2.1 --- Absorption --- p.10 / Chapter 2.4.2.2 --- Distribution --- p.11 / Chapter 2.4.2.3 --- Metabolism and elimination --- p.11 / Chapter 2.4.2.4 --- Toxicity --- p.12 / Chapter 2.4.3 --- Therapeutic drug monitoring of CsA --- p.13 / Chapter 2.4.3.1 --- CsA trough monitoring --- p.13 / Chapter 2.4.3.2 --- Full AUC monitoring --- p.15 / Chapter 2.4.3.3 --- Limited sampling strategy --- p.16 / Chapter 2.4.3.4 --- Two-hour post dose CsA level monitoring --- p.20 / Chapter 2.4.4 --- Conventional techniques of measuring cyclosporine concentration --- p.23 / Chapter 2.4.4.1 --- High performance liquid chromatography --- p.23 / Chapter 2.4.4.2 --- Non-specific immunoassays --- p.25 / Chapter 2.4.4.3 --- Specific radioimmunoassays --- p.26 / Chapter 2.4.4.4 --- Specific fluorescent polarization immunoassay --- p.26 / Chapter 2.4.4.5 --- Enzyme multiplied immunoassay technique --- p.28 / Chapter 2.4.4.6 --- Cloned enzyme donor immunoassay --- p.29 / Chapter 2.4.4.7 --- Summary for conventional techniques --- p.29 / Chapter 2.5 --- Liquid chromatography mass spectrometry for CsA measurement --- p.30 / Chapter 2.5.1 --- Main components of MS --- p.31 / Chapter 2.5.1.1 --- Specific interfaces to LC --- p.31 / Chapter 2.5.1.2 --- Mass analyzer --- p.33 / Chapter 2.5.1.3 --- Electron multiplier --- p.36 / Chapter 2.5.2 --- Sample preparation for LC-MS/MS for CsA measurement --- p.36 / Chapter 2.5.2.1 --- Liquid-liquid extraction --- p.37 / Chapter 2.5.2.2 --- Solid phase extraction --- p.38 / Chapter 2.5.2.3 --- Column switching --- p.39 / Chapter 2.5.2.4 --- Dilute and shoot --- p.40 / Chapter 2.5.3 --- LC-MS/MS for CsA measurement --- p.40 / Chapter 2.6 --- Summary --- p.42 / Chapter 3. --- Aim of study --- p.43 / Chapter 4. --- Materials and methods --- p.44 / Chapter 4.1 --- Materials --- p.44 / Chapter 4.1.1 --- Chemicals --- p.44 / Chapter 4.1.2 --- Equipment --- p.44 / Chapter 4.1.3 --- Reagent preparation for CsA analysis --- p.45 / Chapter 4.2 --- Methods --- p.48 / Chapter 4.2.1 --- Immunoassay --- p.48 / Chapter 4.2.2 --- Operation of tandem mass spectrometer --- p.48 / Chapter 4.2.2.1 --- Optimization of cone voltage --- p.50 / Chapter 4.2.2.2 --- Optimization of collision energy --- p.50 / Chapter 4.2.3 --- Optimization of LC-MS/MS --- p.51 / Chapter 4.2.3.1 --- Deproteinization procedures of whole blood --- p.52 / Chapter 4.2.3.2 --- Optimization of mobile phase flow rate --- p.52 / Chapter 4.2.3.3 --- Optimization of source temperature --- p.53 / Chapter 4.2.3.4 --- Optimization of the drying gas flow rate --- p.53 / Chapter 4.2.4 --- Matrix interference on MS/MS response --- p.53 / Chapter 4.2.5 --- Analytical performance of CsA on LC-MS/MS --- p.54 / Chapter 4.2.5.1 --- Linearity study --- p.54 / Chapter 4.2.5.2 --- Precision performance --- p.54 / Chapter 4.2.5.3 --- Accuracy performance --- p.54 / Chapter 4.2.5.4 --- The lowest detection limit of the CsA analysis --- p.55 / Chapter 4.2.5.5 --- Correlation study of the CsA analysis --- p.55 / Chapter 4.3 --- CsA pharmacokinetic studies in Chinese patients --- p.56 / Chapter 4.3.1 --- Determining the time point of CsA correlating better with AUC --- p.56 / Chapter 4.3.1.1 --- Patient and method --- p.56 / Chapter 4.3.1.2 --- Statistical analysis --- p.57 / Chapter 4.3.2 --- "Intra-individual variability of CO, C1 and C2" --- p.57 / Chapter 4.3.2.1 --- Patient and method --- p.57 / Chapter 4.3.2.2 --- Statistical analysis --- p.57 / Chapter 5. --- Results and discussion --- p.59 / Chapter 5.1 --- Optimization of MS parameters --- p.5 9 / Chapter 5.1.1 --- Optimization of cone voltage --- p.61 / Chapter 5.1.2 --- Optimization of collision energy --- p.63 / Chapter 5.2 --- Optimization of LC-MS/MS --- p.63 / Chapter 5.2.1 --- Optimization of mobile phase flow rate --- p.63 / Chapter 5.2.2 --- Optimization of ion source temperature and drying gas flow rate --- p.67 / Chapter 5.3 --- Matrix interference on MS/MS response --- p.69 / Chapter 5.4 --- Analytical performances of CsA on LC-MS/MS method --- p.71 / Chapter 5.4.1 --- Linearity --- p.71 / Chapter 5.4.2 --- Precision performance --- p.71 / Chapter 5.4.3 --- Accuracy performance --- p.72 / Chapter 5.4.4 --- The lowest limit of detection --- p.73 / Chapter 5.4.5 --- Correlation study of the CsA analysis --- p.80 / Chapter 5.5 --- The correlation between CsA at different point and AUCo-6 --- p.84 / Chapter 5.6 --- "Intra-individual variability of CO, C1 and C2" --- p.88 / Chapter 5.7 --- Therapeutic ranges of C2 --- p.90 / Chapter 5.8 --- Practical consideration for C2 measurement by LC-MS/MS method --- p.94 / Chapter 6. --- Conclusions --- p.97 / References --- p.98
715

Qualidade de vida relacionada à saúde e sintomas depressivos em pacientes transplantados renais / Health-related quality of life and depressive symptoms in kidney transplant patients

La Gamba, Janaina Guerra Gonçalves 16 December 2011 (has links)
Introdução: Doença Renal Crônica (DRC) consiste, principalmente, na redução da capacidade dos rins em filtrar substâncias tóxicas, acarretando alterações metabólicas e hormonais. Em fases terminais, a terapia renal substitutiva (TRS) torna-se necessária, e o transplante renal tem sido relatado como a melhor opção terapêutica e de reabilitação para pacientes com DRC. Entretanto a DRC e o transplante renal podem afetar a qualidade de vida relacionada à saúde (QVRS) desses pacientes, podendo ser influenciada por aspectos da saúde física e mental, tais como os sintomas depressivos (SDs). Objetivos: Caracterizar os pacientes com DRC, após transplante renal, em um município do estado de São Paulo quanto aos aspectos sociodemográficos, econômicos e clínicos; descrever a QVRS e os SDs; correlacionar a QVRS e os fatores sociodemográficos, econômicos e clínicos; comparar a QVRS, segundo as dimensões do SF-36, entre os pacientes sem e com SDs e correlacionar a QVRS com os SDs. Material e Método: Trata-se de um estudo transversal, de natureza quantitativa, que incluiu pacientes que realizaram transplante renal entre 6 e 24 meses retroativos da data de início da coleta de dados, maiores de 18 anos e faziam acompanhamento no ambulatório de Transplante Renal do HCFMRP-USP, na cidade de Ribeirão Preto-SP. Foram excluídos os pacientes que apresentavam instabilidade clínica, o que totalizou a inclusão de 60 pacientes no estudo. Os instrumentos utilizados foram: instrumento para caracterização dos participantes, o qual foi adequado ao estudo e submetido à avaliação de conteúdo, Medical OutcomesStudy (MOS SF-36) para avaliação da QVRS e o Inventário de Depressão de Beck (IDB) para avaliar os SDs. Os dados foram obtidos por meio de entrevista individual com o paciente e de consulta ao prontuário. A coleta de dados ocorreu de abril a agosto de 2011. O projeto foi aprovado pelo Comitê de Ética em Pesquisa da Escola de Enfermagem de Ribeirão Preto - Universidade de São Paulo. A análise dos dados constou da análise estatística descritiva; coeficiente de correlação de Pearson (r) para verificar a correlação entre os domínios do SF-36 com o escore total do IBD; análise de variância (ANOVA) para comparar os domínios do SF-36, nos grupos com ausência e com presença de SD; Teste Exato de Fisher para verificar a associação entre as variáveis qualitativas relacionadas ao escore de IDB e às diversas variáveis independentes, além disso, a quantificação da associação foi mensurada por meio de modelos de regressão logística na qual calculamos o OddsRatio Bruto com seus respectivos intervalos de confiança de 95%. Todas as análises estatísticas foram realizadas com a utilização do software estatístico SAS® 9.0. Valores de p menores que 0,05 foram considerados significativos. Resultados: Dos 60 pacientes, 51 eram adultos e 9 idosos; 41 eram homens e 19 eram mulheres. Os domínios do SF-36 que obtiveram menores escores médios foram: aspectos físicos (59,58), capacidade funcional (64,67) e vitalidade (71,42), e os que obtiveram maiores escores médios foram: aspectos sociais (79,79), dor (78,12) e aspectos emocionais (75,56). Quanto aos escores do IDB, 43 pacientes apresentaram ausência de SDs, 12 apresentaram disforia e 5 apresentaram SDs classificados entre leves e moderados. Não possuir trabalho aumentou a chance em 7,7 vezes de ter SDs que ter trabalho. Os pacientes com ausência de SDs apresentaram escores médios mais elevados nos domínios do SF-36, refletindo melhor QVRS, quando comparados aos pacientes com algum grau de SDs, com notória diferença na comparação (p<0,05). Encontramos correlações negativas entre os domínios do SF-36 e os escores do IDB, ou seja, à medida que aumentaram os escores de SDs, decresceram os escores médios nos domínios de QVRS. Tais correlações apresentaram p valor <0,05, exceto para o domínio estado geral de saúde. Conclusão: A presença de SDs se relacionou negativamente com a QVRS dos pacientes transplantados renais, evidenciando a necessidade de incluir a avaliação dos sintomas depressivos e respectivos atendimentos das alterações quando identificadas, na prática clínica que engloba a atuação do enfermeiro, para otimizar a QVRS desses pacientes. / Introduction: Chronic Kidney Disease (CKD) mainly involves the decrease in the kidney\'s ability to filter toxic substances, causing metabolic and hormonal alterations. In terminal stages, renal replacement therapy (RRT) becomes necessary, and kidney transplantation has been reported as the best treatment and rehabilitation option for CKD patients. CKD and the kidney transplantation can affect these patients\' healthrelated quality of life (HRQoL) though, which can be influenced by physical and mental health aspects, including depressive symptoms (DS). Aims: Characterize CKD patients after kidney transplantation in a city in São Paulo State regarding socio-demographic, economic and clinical aspects; describe HRQoL and DS; correlate HRQoL with the socio-demographic, economic and clinical factors; compare HRQoL, according to the SF-36 dimensions, between patients with and without DS and correlate HRQoL with the DS. Material and Method: This quantitative and crosssectional study included patients who underwent a kidney transplantation between 6 and 24 months before the start of data collection, over 18 years of age and monitored at the Kidney Transplantation outpatient clinic of HCFMRP-USP in RibeirãoPreto-SP, Brazil. Clinically unstable patients were excluded, totaling 60 patients included in the study. The following instruments were used: patient characterization instrument, which was adapted to the study and submitted to content assessment, Medical Outcomes Study (MOS SF-36) for HRQoL assessment and Beck\'s Depression Inventory (BDI) for the assessment of DS. Data were collected through an individual interview with the patient and consultation of patient files. Data collection took place between April and August 2011. Approval for the project was obtained from the Institutional Review Board at the University of São Paulo at RibeirãoPreto College of Nursing. Data analysis comprised descriptive statistical analysis; Pearson\'s correlation coefficient (r) to check the correlation between the SF-36 domains and the total BDI score; variance analysis (ANOVA) to compare the SF-36 domains in the groups with and without DS; Fisher\'s Exact Test to verify the association between the qualitative variables related to the BDI score and the different independent variables. In addition, the association was quantified through logistic regression models, in which the Gross Odds Ratio was calculated with its respective 95% confidence intervals. SAS® 9.0 statistical software was used for all statistical analyses. P-values inferior to 0.05 were considered significant. Results: 51 out of 60 patients were adults and 9 elderly; 41 were men and 19 women. The SF-36 domains with the lowest mean scores were: physical aspects (59.58), functional capacity (64.67) and vitality (71.42); while the domains with the highest mean scores were: social aspects (79.79), pain (78.12) and emotional aspects (75.56). As for the BDI scores, 43 patients presented absence of DS, 12 dysphoria and 5 DS classified between mild and moderate. Not having a job increased the chance of DS by 7.7 times. Patients without DS obtained higher mean scores on the SF-36 domains, reflecting a better HRQoL in comparison with patients with some degree of DS, with a statistically significant difference (p<0.05). We found negative correlations between the SF-36 domains and the BDI scores, that is, to the extent that DS scores increased, the mean scores on the HRQoL domains dropped. The p-value for these correlations was <0.05, except for the general health status domain. Conclusion: The presence of DS was negatively related with the HRQoL of kidney transplant patients, evidencing the need to include the assessment of depressive symptoms and attend to the alterations when identified in clinical practice, which includes nursing actions, in order to improve these patients\' HRQoL.
716

MiRNAs in kidney disease / MiRNAs dans la maladie rénale

Papadopoulos, Theofilos 28 November 2016 (has links)
Les microARNs sont reconnus comme des régulateurs essentiels de l'expression des protéines. Des anomalies dans leur fonction sont associées au développement de nombreuses pathologies.tiel des microARNs en tant que biomarqueurs ou cibles thérapeutiques dans une grande variété de pathologies. Dans le cadre de cette thèse, nous avons étudié :1) L'association des microARNs urinaires avec l'évolution de la maladie rénale chronique (MRC) chez l'adulte. La prévalence de la MRC est actuellement estimée à 5-10% de la population et est en constante augmentation. La détection précoce et l'identification de patients ayant une MRC progressant rapidement vers l'insuffisance rénale sont la clé pour une meilleure prise en charge de ces patients. Actuellement les outils non-invasifs comme l'albuminurie ou l'estimation du débit de filtration glomérulaire manquent de précision. Dans notre travail, nous avons tenté d'identifier les modifications urinaires des microRNAs afin d'identifier de nouveaux biomarqueurs non-invasifs associés à la progression de la MRC. Nous avons analysé les modifications des microARNs urinaires par séquençage à haut débit dans des échantillons d'urine de 70 patients atteints de MRC et corrélé leurs profils d'expression à la progression de la maladie. Cela a amené à l'identification de 25 microARNs urinaires (pvalue ajustée <0.05) potentiellement associés à la progression de la MRC. Parmi ceux-là, quatre microARNs (hsa-miR-34c-5p, hsa-miR-410-3p, hsa-miR-301b-3p, and hsa-miR-145-5p) ont été sélectionnés pour être validés dans une cohorte indépendante de 52 patients atteints de MRC. L'augmentation de l'abondance urinaire de hsa-miR-145-5p a été confirmée comme étant associée à la progression de la MRC. Des analyses in vitro de l'effet de l'inhibition de hsa-miR-145-5p dans les cellules rénales ont mis en évidence que ce microARN semblait être impliqué dans le processus de nécrose. En conclusion, cette étude nous a permis d'identifier hsa-miR-145-5p comme Ainsi, de nombreuses études s'intéressent au potenmarqueur potentiel de la progression de la MRC. 2) La présence de microARNs urinaires associés à la néphropathie obstructive, une maladie fréquemment rencontrée chez les enfants qui peut conduire, dans les cas graves, à l'insuffisance rénale précoce. Dans cette étude, nous avons utilisé la biologie des systèmes et avons combiné des données microARN et ARNm de néphropathie obstructive humaine et animale pour obtenir des informations sur les mécanismes possibles impliqués dans cette maladie. En particulier, nous avons étudié simultanément le miRNome urinaire de nourrissons présentant une obstruction de la jonction pyélo-urétérale et le miRNome et le transcriptome tissulaire rénal chez la souris dans le modèle animal d'obstruction urétérale unilatéral (OUU) partiel et néonatal. Plusieurs centaines de microARNs et d'ARNms étant modifiés, la combinaison des microARNs des deux espèces avec les ARNms cibles associés a permis de sélectionner les 5 microARNs et 35 ARNms les plus fortement associés à la néphropathie obstructive. Une validation in vitro et in vivo a mis en avant que let-7a-5p et miR-29-3p ainsi que deux nouvelles cibles potentielles, l'E3 ubiquitin-protein ligase (DTX4) et neuron navigator 1 (NAV1) étaient dérégulées au cours de cette pathologie. Cette étude est la première à corréler le modèle animal d'OUU partiel et néonatal avec l'obstruction pyélo-urétérale chez l'Homme dans une analyse intégrée de biologie des systèmes. Nos résultats ont révélé let-7a et miR-29b en tant que molécules potentiellement impliquées dans le développement de la fibrose dans la néphropathie obstructive via le contrôle de DTX4 chez l'homme et la souris, ce qui n'aurait pas été identifiable autrement. / MicroRNAs are now recognized as key players in the regulation of proteins and any abnormality in their function is a cause for pathway instability, leading to pathological conditions. Numerous reports from a variety of pathologies provide new data about microRNAs function, their targets and their potential as biomarkers and possible ways to control microRNAs' expression for potential therapeutic purpose. A number of reports also connect microRNAs with pathological conditions in the kidney and point to the use of microRNAs as biomarkers for diagnosis and prognosis of kidney disease in blood, serum, tissue and urine samples. In this thesis, we researched:1) A possible role of the microRNAs in the progression of adult chronic kidney disease (CKD), a disease representing a global burden with the tendency to rise worldwide. Progression of CKD is still very hard to detect non-invasively with the currently used clinical tools (eGFR and albuminuria). In our work we studied alterations of the level of the microRNAs in human urine samples of patients with fast or slow progression of CKD, in order to identify new potential biomarkers for non-invasive progression of CKD. Using Next Generation Sequencing, we analyzed urinary microRNA modifications in urine samples of 70 patients with established CKD and correlated their expression profiles to disease progression. This lead to the identification of 25 urinary microRNAs significantly associated to CKD progression (adjusted pvalue<0.05). Among those, four microRNAs (hsa-miR-34c-5p, hsa-miR-410-3p, hsa-miR-301b-3p, and hsa-miR-145-5p) were selected for validation in an independent cohort of 52 patients with CKD. Increased urinary abundance of hsa-miR-145-5p was confirmed to be associated to progression of CKD. In vitro exploration of the effects of hsa-miR-145-5p inhibition in human kidney cells showed that the microRNA seemed to be involved in necrotic processes. In conclusion we have identified hsa-miR-145-5p as potential urinary microRNA marker of CKD progression. 2) The identification of microRNAs associated to obstructive nephropathy, a frequently encountered disease in children that can lead, in severe cases, to end stage renal disease (ESRD). In this study we used a comprehensive system biology analysis in which we combined micro- and mRNA data from human and animal obstructive nephropathy to obtain information on possible mechanisms involved in this disease. In particular, we have studied in parallel the urinary miRNome of infants with ureteropelvic junction (UPJ) obstruction and the kidney tissue miRNome and transcriptome of the corresponding neonatal partial unilateral ureteral obstruction (UUO) mouse model. Several hundreds of microRNAs and mRNAs displayed changed abundance during disease. Combination of microRNAs in both species and associated mRNAs let to the prioritization of 5 microRNAs and 35 mRNAs associated to disease. In vitro and in vivo validation identified consistent dysregulation of let-7a-5p and miR-29-3p and new potential targets, E3 ubiquitin-protein ligase (DTX4) and neuron navigator 1 (NAV1). Our study is the first to correlate a mouse model of neonatal partial UUO with human UPJ obstruction in a comprehensive systems biology analysis. Our data revealed let-7a and miR-29b as molecules potentially involved in the development of fibrosis in UPJ obstruction via the control of DTX4 in both man and mice that would not be identified otherwise.
717

Platelet reactivity and comorbidities in acute coronary syndrome / Trombocytreaktivitet och komorbiditet vid akut koronart syndrom

Björklund, Fredrik January 2012 (has links)
Background In the event of an acute coronary syndrome (ACS), the risk of death and complications such as stroke and re-infarction is high during the first month. Diabetes, impaired kidney function, elevated markers of systemic inflammation and high level of platelet reactivity have all been associated with worsened prognosis in ACS patients. Impaired kidney function is a condition with high cardiovascular morbidity and there is an established association between level of kidney function and outcome in the event of an ACS. Aims We sought to investigate the level of platelet reactivity during the first days of an ACS and specifically the level of platelet reactivity in patients with different conditions associated with worsened prognosis in the event of an ACS. We also wanted to investigate the prognostic impact of baseline levels of cystatin C as well as the importance of decreasing kidney function during the first days of an ACS. Methods We included 1028 unselected patients with ACS or suspected ACS during the years 2002 and 2003, of which 534 were diagnosed with an acute myocardial infarction (AMI). Blood samples for measuring platelet aggregation, cystatin C levels and other clinically important biomarkers were collected day 1, 2, 3 and 5 following admission. Platelet reactivity was measured using 2 different methods. Platelet aggregation was measured using Pa-200, a particle count method, based on scattering of laser light. PFA 100 is a method of measuring primary hemostasis in whole blood. Results Platelet aggregation and comorbidities. We found an increase in platelet aggregation when an ACS was complicated by an infection and there was an increased frequency of aspirin non-responsiveness in patients suffering from pneumonia during the first days of an ACS. Furthermore, we found an independent association between levels of C-reactive protein and platelet aggregation. During the first 3 days following an acute myocardial infarction, platelet aggregation increased despite treatment with anti-platelet agents. Platelet aggregation was found to be more pronounced in patients with diabetes. Patients with impaired kidney function, showed increased platelet aggregation compared to patients with normal renal function, however, this difference was explained by older age, higher prevalence of DM and levels of inflammatory biomarkers. We found no independent association between chronic kidney disease (CKD) and levels of platelet aggregation. Kidney function and outcome Serum levels of cystatin C on admission had an independent association with outcome following an acute myocardial infarction. With a mean follow-up time of 2.9 years, the adjusted HR for death was 1.62 (95% CI 1.28-2.03; p&lt;0.001) for each unit of increase in cystatin C on admission. The level of dynamic changes in cystatin C during admission for an acute myocardial infarction was independently associated with prognosis in patients with normal or mild impairment of renal function. The adjusted HR for death was 10.1 (95% CI 3.4-29.9; p&lt;0.001). Conclusion In patients suffering from an AMI platelet aggregation increases during the first days, despite anti-platelet treatment. Diabetes, age and biomarkers of inflammation are independently associated with platelet aggregation. Admission levels of cystatin C as well as changes in cystatin C levels during hospitalisation are independently associated with outcome.
718

Calreticulin in kidney function and disease: chronic low level of calreticulin impairs Ca2+ homeostasis leading to mitochondrial dysfunction and chronic renal injury / Bedeutung der Calreticulin in Nierenfunktion und -Erkrankung: chronisch niedrige Calreticulin-Konzentration beeinträchtigt die Ca2+-Homöostase und führt zu mitochondrialer Dysfunktion und chronischer Nierenschädigung

Bibi, Asima 11 October 2012 (has links)
No description available.
719

Stories of chronic kidney disease: listening for the unsayable.

Schick Makaroff, Kara Lee 02 September 2011 (has links)
Chronic kidney disease (CKD) is frequently described as a chronic illness. It is also a life-threatening illness, although this is rarely discussed. When people with CKD face declining kidney function, they need technological assistance to extend life. Many people receiving treatment will also die within 5 years. The experience of living with CKD is often difficult to articulate, and little is known about the aspects of this illness that are often ineffable, difficult to discuss, or beyond words. The purpose of this dissertation is to present four papers in which I investigate the concept of the unsayable and illuminate how this concept may be helpful in exploring individuals’ stories of living with CKD. Located in social constructionism, this narrative research explores the unsayable aspects of experience for people living with CKD as portrayed through their stories and symbols. In the first paper, I present a concept analysis of the unsayable and I define the unsayable as that which is not expressed yet alluded to through language and may be conscious or unconscious. Although the unsayable is intertwined with language, it also transcends articulation. In the second paper, I offer a qualitative meta-synthesis and I show how people with kidney failure have experienced restricted freedom that brings about distant connection, dependent autonomy, abnormal normalcy, and uncertain hope. In the third paper, I present a narrative inquiry using secondary analysis of 46 interviews conducted over 3 years with 14 people living with CKD. Narrative expressions of the unsayable include the following: living with death, embodied experiences that were difficult to language, that which was unthinkable, unknowable mystery, and that which was untold / unheard. Lastly, I offer a narrative visual analysis of symbols that represent living with CKD for 13 participants. Descriptive themes of the symbols include hopes and inspirations, reflections on “who I am,” and confrontations of illness. Participants’ expressions through symbols are described through stories of memories, emotions, and poetic devices. Consideration of the unsayable may offer insights for nurses who work to support individuals and promote quality of life for those living with this chronic and life-threatening illness. / Graduate
720

Experienced physical functioning and effects of resistance training in patients with chronic kidney disease /

Heiwe, Susanne, January 2004 (has links)
Diss. (sammanfattning) Stockholm : Karol. inst., 2004. / Härtill4 uppsatser.

Page generated in 0.1497 seconds